Crude oil prices tumbled after the U.S. and Iran halted attacks and restarted negotiations, easing supply disruption fears. Stocks ended mixed, with the Dow up 0.5% but the Nasdaq down 0.2% as tech heavyweights diverged. For investors, the relief rally in energy-sensitive sectors is tempered by lingering inflation and rate uncertainty.
Source: twincities.com · thegazette.com
The QQQ ETF, tracking the Nasdaq-100, is recommended by Motley Fool as a retirement cornerstone for young investors, leveraging a 70% tech weighting and top holdings that have returned over 500% since 2023 amidst the AI boom.
The S&P 500 closed at 7,411.98, notching its second straight weekly decline, while the Dow added 235 points and the Nasdaq fell 0.6% amid a rotation from tech to energy. Brent crude’s breach of $100/barrel and new tariffs heighten inflation fears and market uncertainty.
The S&P 500 eked out a 0.7% gain Friday, capped by a 15.3% Amazon rally and a 7.4% Apple decline. Surging oil prices due to Iran tensions are fueling inflation worries, complicating the Fed's rate path and causing violent sector swings. Investors weigh AI monetization hopes against tech valuation risks.
Source: eastbaytimes.com · ktbb.com
Wall Street’s risk-on mood pushed the S&P 500 up 0.9% as AI chipmakers Micron and Nvidia staged a powerful recovery. However, Brent crude’s climb to $91.01 and the 10-year Treasury yield’s rise to 4.63% signal that markets are pricing in renewed inflation risks from U.S.-Iran tensions, potentially forcing the Fed to resume tightening.
U.S. equities ended mixed as Brent crude’s 3.9% slide snapped a four-day rally, while the S&P 500 logged its second straight weekly decline. Tech stocks dragged the Nasdaq lower, and geopolitical risks from the U.S.-Iran war keep energy markets—and interest rates—on edge.
Source: durangoherald.com · pilotonline.com
Stocks ended mixed Friday with the Dow gaining 235 points while the S&P 500 notched its second straight weekly loss. Oil prices slipped after nearing $100 on Iran war fears, but energy market resilience is fading. New tariffs and AI sector jitters added to a complex macro backdrop.
Memory stocks are in a bear market despite record AI chip demand, reviving historical boom-bust fears. However, the sector’s consolidation into three disciplined players and structural AI demand suggest the current cycle may be different. For investors in MU and SK Hynix, the key question is whether capital discipline can finally overcome the industry's brutal history.
Source: Micah Zimmerman (us) · fool.com
While the S&P 500 slipped 0.5% on July 16, the decline was entirely attributable to a handful of overvalued AI chip stocks. Nearly three-quarters of index members rose, with healthcare and freight sectors rallying. The sell-off reveals a powerful rotation under the surface that could reshape portfolio allocations.
Investors flee overvalued AI names, pushing Nvidia down 2.2% and briefly below Apple's market cap, while oil spikes on Iran war jitters and Treasury yields ease.
A concentrated sell-off in AI-driven chipmakers slammed the Nasdaq on July 16, even as strong earnings from healthcare and freight companies boosted over 75% of S&P 500 stocks. The divergence underscores a market rotation that threatens index-level returns while creating pockets of opportunity in undervalued sectors. Rising oil prices add a macro risk that could further pressure tech valuations.
Source: thetimes-tribune.com · advocate-news.com
A dual shock hit markets Monday: oil soared on a Strait of Hormuz blockade while AI chip stocks plunged. Brent jumped 7.8% to $81.92, the S&P 500 fell 0.7%, and South Korea’s Kospi cratered 8.9%.
The AI-focused ETF has delivered 23% gains year-to-date, crushing the broader Nasdaq's 13%. With earnings season here, underperforming but fundamentally strong stocks Nvidia and Celestica offer compelling entry points, backed by BofA's bullish outlook on AI infrastructure spending.
Source: The Motley Fool · fool.com
Technology stocks outperformed in a bifurcated market as SK Hynix’s Wall Street debut and buy-the-dip activity drove a 1.74% Nasdaq gain. Meanwhile, a geopolitical shock sent oil above $76/barrel and the 10-year yield toward 4.60%, punishing small caps.
Source: Panos Mourdoukoutas (us) · Panos Mourdoukoutas (us)
The Nasdaq tumbled 1.16% and the PHLX Semiconductor Index plunged 4.65% as Samsung’s earnings failed to impress overbought investors, triggering a rotation out of AI chip stocks. With Micron down 4.7% and Sandisk off 7.3%, the selloff raises fresh questions about stretched valuations. Upcoming SK Hynix listing will test whether global demand for AI hardware shares has peaked.
AI semiconductor stocks staged a powerful rebound on July 6, with Broadcom up 5.3% and Micron +4.2%, ahead of SK Hynix’s $28 billion Nasdaq IPO. TeraWulf soared 16.9% on a $19 billion data center deal with Anthropic, highlighting the capital intensity and volatility driving the AI trade.
Source: thetimes-tribune.com · broomfieldenterprise.com
A Micron board member unloaded 1,300 shares at $1,150.43, cashing out $1.5 million after the stock’s meteoric rise to a $1.1 trillion market cap. The sale trims just 6.83% of her position, but against a backdrop of explosive AI‑fueled earnings, it probes whether insiders see peak valuation.
Source: MarketBeat · Americanbankingnews
Nvidia's forward P/E has collapsed to 21.7, in line with the S&P 500, while Meta's $70B+ capex narrative obscures accelerating ad revenue. This deep-value setup in AI leaders could spark a sharp re-rating as H2 earnings season kicks off.
Source: The Motley Fool · finance.yahoo.com
A broad tech sell-off has sent Alphabet, Tesla, and Amazon down over 10%, while the SpaceX IPO fades. With AI stocks showing vulnerability, should investors shift to defensive positions?
Source: The Motley Fool · James Brumley (us)
Despite nearly 66% of S&P 500 stocks climbing, the index posted its second losing week in 13 as heavy selling in AI megacaps like Micron completely negated the broad market rally. Oil prices dropped to pre-Iran crisis levels, boosting transportation and healthcare stocks, while Eli Lilly soared 7.1% on European drug approvals.